| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.055 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.016 | 0.8 |